About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
A
CAR T-Cell Therapy Side Effects for Blood Cancers
By
CancerGRACE
FEATURING
Aaron Goodman
September 6, 2022
1 Comment
Login to view comments.
Click here to Login
Featured Video
15:50
Seagen
Efficacy and Safety Data of a First Line Treatment Option in Patient…
Feat.
A. Forman
Featured Video
17:12
Seagen
Strategies for Managing Toxicities Associated with a First Line Trea…
Feat.
A. Forman
Related Content
AUTOPLAY
ON
09:18
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Random…
Feat.
J. Westin
09:45
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Therapeutic Options for Pts With Primary …
Feat.
M. Kamdar
20:19
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Highlights of Hematologic Malignancies - …
Feat.
A. Paulus
12:38
SOHO 2022 Tenth Annual Meeting
SOHO 2022 DEBATE: Bispecific Antibodies vs. CAR-T for R/R MM - Defen…
Feat.
S. Usmani
15:24
Michael Soulen
Interventional Delivery of CAR-T Therapy
31:51
Indy Hematology Review
Treating Multiple Myeloma: The Cure Is Within Reach - Goals of Curre…
Feat.
K. Anderson
62:02
UChicago Medicine
New Treatment Strategies in DLBCL
Feat.
L. Sehn
30:59
Houston Methodist Hospital
Overview of Advances in Multiple Myeloma
Feat.
S. Ganguly
44:49
Dana-Farber Cancer Institute
Recent Updates in Multiple Myeloma
Feat.
K. Anderson
15:31
SOHO 2022 Tenth Annual Meeting
SOHO 2022: What's Next in Aggressive B-Cell Lymphoma?
Feat.
L. Sehn
24:12
SIR 2022 Coverage
New and Evolving Clinical Trials: Embolotherapy
Feat.
M. Soulen
09:18
ESMO 2022 Conference Coverage
ESMO 2022 Congress Highlights: Hematological Malignancies
Feat.
I. Glimelius
21:38
Rahul Banerjee
CAR-T Therapy in Myeloma: What's Here and What's Coming So…
42:09
University of Colorado Department of Medicine
Immunotherapy in Lymphomas: The Present and the Future
Feat.
M. Kamdar
48:05
Yale Cancer Center
ALL - Progress in Research and Therapy in 2022
Feat.
H. Kantarjian
06:01
ASH 2022 Conference Coverage
ASH 2022 Outcomes of R/R Double Hit Lymphoma: A Multicenter Observat…
Feat.
S. Desai
28:07
Indy Hematology Review
Controversies and Recommendations for the Treatment of ALL and Lymph…
Feat.
W. Stock
33:11
Total Health
Bispecific Antibodies and CAR T-Cells for NHL: Challenges and Opport…
Feat.
K. Komanduri
06:41
Hamza Hashmi
Idecabtagene Vicleucel vs. Ciltacabtagene Autoleucel: A Sophie'…
21:16
UChicago Medicine
Myeloma 2022: Challenges and Path Forward
Feat.
A. Jakubowiak
